Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against Alpha, Beta, Delta and Omicron variants of concern

The neutralizing antibody responses were significantly elevated after 3rd dose of BBV152/Covaxin against the B.1 (19.11 fold) variant including Delta (16.51 fold), Beta (14.70 fold) and Omicron (18.53 fold) Variants of concern in comparison with two dose vaccine, providing assurance of a protective...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of travel medicine 2022-05, Vol.29 (3)
Hauptverfasser:	Deshpande, Gururaj Rao, Yadav, Pragya D, Abraham, Priya, Nyayanit, Dimpal A, Sapkal, Gajanan N, Shete, Anita M, Gupta, Nivedita, Vadrevu, Krishna Mohan, Ella, Raches, Panda, Samiran, Bhargava, Balram
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antibody response Coronaviruses Councils COVID-19 vaccines Drug dosages Immune response Medical research Medicine Neutralizing Proteins Severe acute respiratory syndrome coronavirus 2 Travel medicine Vaccines Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!